analyst
NYSE · COR
Cencora, Inc.
Healthcare · Medical - Distribution
$321.57
Up+$0.62 (+0.19%)
Updated Sep 14, 2026, 5:01 AM
SID Score
5.4/10
Composite research score
Smart Money
55/100
Neutral
- Market cap
- 66.71B
- P/E ratio
- 42.94
- Dividend yield
- 0.70%
- 52-week range
- $244.82 – $376.92
- Volume
- 844.06K
- Avg. volume
- 1.54M
Price performance
COR price history
1M range · 19 trading sessions · Daily adjusted prices
COR closed at $321.57 after 19 trading sessions, up 2.90% for the selected period.
- Last close
- $321.57
- Period change
- +2.90%
- Period low
- $312.52
- Period high
- $337.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $323.99 | $325.125 | $317.96 | $321.57 | 844.06K |
| Sep 10, 2026 | $326.34 | $327.90 | $320.91 | $320.95 | 1.35M |
| Sep 9, 2026 | $322.24 | $326.99 | $321.915 | $323.32 | 1.22M |
| Sep 8, 2026 | $327.55 | $330.00 | $323.05 | $324.69 | 2.2M |
| Sep 4, 2026 | $333.48 | $336.01 | $330.201 | $330.95 | 1.03M |
| Sep 3, 2026 | $337.90 | $338.71 | $334.87 | $337.22 | 1.09M |
| Sep 2, 2026 | $330.62 | $337.91 | $330.62 | $336.36 | 1.4M |
| Sep 1, 2026 | $325.97 | $331.65 | $325.92 | $330.97 | 1.52M |
| Aug 31, 2026 | $321.11 | $326.57 | $319.04 | $323.60 | 1.39M |
| Aug 28, 2026 | $322.30 | $323.74 | $320.39 | $322.03 | 628.86K |
| Aug 27, 2026 | $324.35 | $324.68 | $320.465 | $321.23 | 1.07M |
| Aug 26, 2026 | $328.39 | $330.995 | $326.30 | $327.79 | 841.57K |
| Aug 25, 2026 | $322.68 | $328.51 | $321.43 | $328.06 | 1.11M |
| Aug 24, 2026 | $317.76 | $324.58 | $317.65 | $323.77 | 760.4K |
| Aug 21, 2026 | $314.74 | $320.2137 | $313.13 | $318.04 | 905.4K |
| Aug 20, 2026 | $314.77 | $318.23 | $312.605 | $314.69 | 1.18M |
| Aug 19, 2026 | $314.03 | $322.50 | $312.02 | $317.10 | 1.18M |
| Aug 18, 2026 | $315.99 | $320.00 | $313.92 | $316.13 | 1.03M |
| Aug 17, 2026 | $312.00 | $318.23 | $311.43 | $312.52 | 992.05K |
Latest COR news
The latest Smart Investors Daily articles mentioning COR.
Stock researchResearch & News · SEC Filings
Loading stock research…